MEC Practice Academy 11.19
|Articles|May 6, 2022

Racism in health care increases vaccine hesitancy in minority groups

Author(s)Todd Shryock

Study shows that 10% of minorities refused COVID vaccines because of past racial discrimination experiences

One in ten people from ethnic minority groups who refused a vaccine experienced racial discrimination in a medical setting since the start of the pandemic. They also experienced twice as many incidents of racial discrimination compared to those who were vaccinated, according to a study published in the Journal of the Royal Society of Medicine.

The study authors said that this illustrates how the effects of racial discrimination creates low confidence in the health system to handle the pandemic, which led to vaccine refusal.

The study participants included 633 adults belonging to ethnic minority groups who were offered a COVID-19 vaccine between December 2020 and June 2021. 6.69% of participants who had refused the vaccine reported they had experienced poorer service or treatment than other people in a medical setting because of their race or ethnicity.

The researchers said that the findings underscore how government agencies must work to regain trust from ethnic minority groups to increase vaccination rates among these diverse groups. Public health campaigns to increase COVID-19 vaccination rates should not only focus on building trust in the vaccines, but also to prevent racial and ethnic discrimination and support people who have experienced it.

They also pointed out that failure to tackle racial discrimination would lead to a widening of systemic inequalities putting more ethnic minority lives at risk.


Related to this article

Sethu Reddy: ©Sethu Reddy
Prior authorization, step therapy and shifting coverage rules keep patients from obesity drugs with proven benefits, an endocrinologist argues — and the long-term savings make the case for broader access.
Is more health care access always better?: ©Yodiyim - stock.adobe.com
In 590,282 California heart attack hospitalizations, a new PCI-capable facility within a 30-minute drive lowered 30-day mortality 20% in communities without prior access but did not change survival where the procedure was already available.